Islet delta-cell architecture is remodelled in the human pancreas during type 1 diabetes
- PMID: 40473678
- PMCID: PMC12141693
- DOI: 10.1038/s41598-025-04471-w
Islet delta-cell architecture is remodelled in the human pancreas during type 1 diabetes
Abstract
Delta cells participate in regulating hormone secretion in adjacent alpha- and beta cells and a general assumption is that cells with a shorter distance to the secreting cell receive a higher concentration of the secretory compounds. Isolated islets obtained from donors with type 1 diabetes have a reduced glucagon secretion during low glucose levels, but adding a somatostatin receptor inhibitor increases the glucagon secretion. Despite this, information regarding the delta-cell architecture during diabetes is sparse. The aim of the current study was to determine intra-islet and extra-islet delta-cell architecture in the pancreas during long-standing type 1 diabetes or type 2 diabetes. Pancreatic tissue from nine donors with long-standing type 1 diabetes, six donors with type 2 diabetes, and 13 donors without diabetes were obtained. Sections co-stained for somatostatin, glucagon, and insulin were manually examined. There was an approximately two-fold higher number of alpha cells directly adherent to delta cells in subjects with type 1 diabetes compared with non-diabetic subjects. The delta cells were more peripherally located within the islets of donors with type 1 diabetes. The density of extra-islet single delta cells in the acinar region was more than three-fold higher in type 1 diabetes compared with non-diabetic subjects. No differences in delta-cell architecture could be determined in type 2 diabetes compared to non-diabetic subjects. In conclusion, the islet delta-cell architecture in human type 1 diabetes is remodelled. The higher number of alpha cells directly adherent to delta cells in type 1 diabetes likely increases the alpha cells' exposure to somatostatin. This finding may be a link partly explaining the reduced glucagon response to hypoglycemia in type 1 diabetes.
Keywords: Alpha cell; Delta cell; Hypoglycemia; Somatostatin; Type 1 diabetes; Type 2 diabetes.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Quantitative analysis of islet prohormone convertase 1/3 expression in human pancreas donors with diabetes.Diabetologia. 2024 Dec;67(12):2771-2785. doi: 10.1007/s00125-024-06275-5. Epub 2024 Oct 15. Diabetologia. 2024. PMID: 39404844 Free PMC article.
-
Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.Islets. 2011 Jul-Aug;3(4):166-74. doi: 10.4161/isl.3.4.15875. Epub 2011 Jul 1. Islets. 2011. PMID: 21633185 Free PMC article.
-
Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice.Mol Metab. 2021 Mar;45:101166. doi: 10.1016/j.molmet.2021.101166. Epub 2021 Jan 20. Mol Metab. 2021. PMID: 33484949 Free PMC article.
-
Distinctions between the islets of mice and men: implications for new therapies for type 1 and 2 diabetes.Endocr Pract. 2013 Mar-Apr;19(2):301-12. doi: 10.4158/EP12138.RA. Endocr Pract. 2013. PMID: 23186955 Review.
-
Organisation of the human pancreas in health and in diabetes.Diabetologia. 2020 Oct;63(10):1966-1973. doi: 10.1007/s00125-020-05203-7. Epub 2020 Sep 7. Diabetologia. 2020. PMID: 32894306 Free PMC article. Review.
References
-
- Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H. & Forsham, P. H. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science182 (4108), 171–173. 10.1126/science.182.4108.171 (1973). - PubMed
-
- Singer-Granick, C., Hoffman, R. P., Kerensky, K., Drash, A. L. & Becker, D. J. Glucagon responses to hypoglycemia in children and adolescents with IDDM. Diabetes Care. 11 (8), 643–649. 10.2337/diacare.11.8.643 (1988). - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical